Compugen (CGEN) Common Equity (2009 - 2026)
Compugen recorded quarterly Common Equity of $95.4 million in Q1 2026, down 7.18% quarter-over-quarter from $102.7 million in Q4 2025.
Compugen's Common Equity history runs 12 years deep, the most recent figure standing at $95.4 million for Q1 2026.
- In Q1 2026, Common Equity changed N/A year-over-year to $95.4 million; the TTM figure through Mar 2026 stood at $95.4 million (changed N/A YoY), while the FY2025 annual figure was $102.7 million, up 87.08% from the prior year.
- Common Equity came in at $95.4 million for Q1 2026 at Compugen, down from $102.7 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $102.7 million in Q4 2025 to a low of $54.9 million in Q4 2024.
- A 5-year average of $79.2 million and a median of $77.7 million in 2022 frame the typical range for Common Equity.
- Across the five-year window, Common Equity slipped 27.19% in 2022 and soared 87.08% in 2025, its largest moves.
- Compugen's Common Equity stood at $77.7 million in 2022, then declined by 15.6% to $65.6 million in 2023, then dropped by 16.24% to $54.9 million in 2024, then surged by 87.08% to $102.7 million in 2025, then declined by 7.18% to $95.4 million in 2026.
- According to Business Quant data, Common Equity over the past three periods registered $95.4 million, $102.7 million, and $54.9 million for Q1 2026, Q4 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.42 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 35.63 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 14.38 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 19.36 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 13.21 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 31.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.08 Bn |
| 10 | Compugen | 234.03 Mn | 142.28 Mn | 352,000.00 | 95.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 95.35 Mn |
| Dec 31, 2025 | 102.73 Mn |
| Dec 31, 2024 | 54.91 Mn |
| Dec 31, 2023 | 65.56 Mn |
| Dec 31, 2022 | 77.68 Mn |
| Dec 31, 2021 | 106.69 Mn |
| Dec 31, 2020 | 119.78 Mn |
| Dec 31, 2019 | 38.32 Mn |
| Dec 31, 2018 | 37.24 Mn |
| Dec 31, 2013 | 31.89 Mn |
| Dec 31, 2012 | 17.67 Mn |
| Dec 31, 2011 | 19.58 Mn |
| Dec 31, 2010 | 28.29 Mn |
| Dec 31, 2009 | 27.40 Mn |